Xencor | Beban Penjualan Dan Administrasi

Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.61B 273M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Cytokinetics USD 44.11M 4M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Xencor USD 15.48M 2.98M 2023-12



Xencor Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.